2022 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

2021-11-15 慢性阻塞性肺疾病全球倡议慢性阻塞性肺疾病全球倡议(GOLD)官网

2022年GOLDCOPD诊断、治疗与预防全球策略

中文标题：

英文标题：

2022 GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD

发布机构：

慢性阻塞性肺疾病全球倡议

发布日期：

2021-11-15

简要介绍：

2022年GOLDCOPD诊断、治疗与预防全球策略

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=8b4cf1c002263615, title=2022 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略, enTitle=2022 GLOBAL STRATEGY FOR PREVENTION, DIAGNOSIS AND MANAGEMENT OF COPD, guiderFrom=慢性阻塞性肺疾病全球倡议(GOLD)官网, authorId=0, author=, summary=2022年GOLDCOPD诊断、治疗与预防全球策略, cover=https://img.medsci.cn/20211115/1636983874542_5579292.jpg, journalId=0, articlesId=null, associationId=202, associationName=慢性阻塞性肺疾病全球倡议, associationIntro=null, copyright=0, guiderPublishedTime=Mon Nov 15 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2022年GOLDCOPD诊断、治疗与预防全球策略</span></p>, tagList=[TagDto(tagId=2115, tagName=慢性阻塞性肺疾病), TagDto(tagId=117733, tagName=慢性阻塞性肺疾病与肺心病)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2115, guiderKeyword=慢性阻塞性肺疾病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=9126, appHits=906, showAppHits=0, pcHits=3290, showPcHits=8210, likes=4, shares=98, comments=30, approvalStatus=1, publishedTime=Wed Nov 17 00:08:30 CST 2021, publishedTimeString=2021-11-15, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Nov 15 22:24:23 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Sat Jan 06 12:52:05 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 年黄金袖珍指南.pdf), AttachmentFileName(sort=2, fileName=2022 黄金报告.pdf), AttachmentFileName(sort=3, fileName=2022金色教学滑梯套装.pptx)])

2022 年黄金袖珍指南.pdf

下载请点击：

2022 黄金报告.pdf

下载请点击：

2022金色教学滑梯套装.pptx

下载请点击：

评论区 (26)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2157404, encodeId=82cb215e40467, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf18786573, createdName=ms4000001364210815, createdTime=Tue Sep 12 21:43:05 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2116910, encodeId=068c2116910a4, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/334968fc6a8f41a7a0097ebac454153d/ee114cc25e594a55aa188e09f9cb7b19.jpg, createdBy=80058133704, createdName=医路有你*, createdTime=Tue Feb 28 16:04:36 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116951, encodeId=ea6421169515c, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c8562988, createdName=ms7000001379242149, createdTime=Tue Feb 28 21:12:30 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2097755, encodeId=05a3209e75549, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b14243701, createdName=13e2e3cbm26暂无昵称, createdTime=Tue Nov 01 09:29:42 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224261, encodeId=047e1224261c2, content=学到很多东西！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Fri Jun 03 16:19:29 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
2023-09-12 ms4000001364210815 来自福建省

学到了

28 0
[GetPortalCommentsPageByObjectIdResponse(id=2157404, encodeId=82cb215e40467, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf18786573, createdName=ms4000001364210815, createdTime=Tue Sep 12 21:43:05 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2116910, encodeId=068c2116910a4, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/334968fc6a8f41a7a0097ebac454153d/ee114cc25e594a55aa188e09f9cb7b19.jpg, createdBy=80058133704, createdName=医路有你*, createdTime=Tue Feb 28 16:04:36 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116951, encodeId=ea6421169515c, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c8562988, createdName=ms7000001379242149, createdTime=Tue Feb 28 21:12:30 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2097755, encodeId=05a3209e75549, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b14243701, createdName=13e2e3cbm26暂无昵称, createdTime=Tue Nov 01 09:29:42 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224261, encodeId=047e1224261c2, content=学到很多东西！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Fri Jun 03 16:19:29 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
2023-02-28 医路有你* 来自河南省

太好了

32 0
[GetPortalCommentsPageByObjectIdResponse(id=2157404, encodeId=82cb215e40467, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf18786573, createdName=ms4000001364210815, createdTime=Tue Sep 12 21:43:05 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2116910, encodeId=068c2116910a4, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/334968fc6a8f41a7a0097ebac454153d/ee114cc25e594a55aa188e09f9cb7b19.jpg, createdBy=80058133704, createdName=医路有你*, createdTime=Tue Feb 28 16:04:36 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116951, encodeId=ea6421169515c, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c8562988, createdName=ms7000001379242149, createdTime=Tue Feb 28 21:12:30 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2097755, encodeId=05a3209e75549, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b14243701, createdName=13e2e3cbm26暂无昵称, createdTime=Tue Nov 01 09:29:42 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224261, encodeId=047e1224261c2, content=学到很多东西！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Fri Jun 03 16:19:29 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
2023-02-28 ms7000001379242149 来自河南省

学到了

26 0
[GetPortalCommentsPageByObjectIdResponse(id=2157404, encodeId=82cb215e40467, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf18786573, createdName=ms4000001364210815, createdTime=Tue Sep 12 21:43:05 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2116910, encodeId=068c2116910a4, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/334968fc6a8f41a7a0097ebac454153d/ee114cc25e594a55aa188e09f9cb7b19.jpg, createdBy=80058133704, createdName=医路有你*, createdTime=Tue Feb 28 16:04:36 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116951, encodeId=ea6421169515c, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c8562988, createdName=ms7000001379242149, createdTime=Tue Feb 28 21:12:30 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2097755, encodeId=05a3209e75549, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b14243701, createdName=13e2e3cbm26暂无昵称, createdTime=Tue Nov 01 09:29:42 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224261, encodeId=047e1224261c2, content=学到很多东西！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Fri Jun 03 16:19:29 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
2022-11-01 13e2e3cbm26暂无昵称

学习

45 0
[GetPortalCommentsPageByObjectIdResponse(id=2157404, encodeId=82cb215e40467, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aaf18786573, createdName=ms4000001364210815, createdTime=Tue Sep 12 21:43:05 CST 2023, time=2023-09-12, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2116910, encodeId=068c2116910a4, content=太好了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220428/334968fc6a8f41a7a0097ebac454153d/ee114cc25e594a55aa188e09f9cb7b19.jpg, createdBy=80058133704, createdName=医路有你*, createdTime=Tue Feb 28 16:04:36 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2116951, encodeId=ea6421169515c, content=学到了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=737c8562988, createdName=ms7000001379242149, createdTime=Tue Feb 28 21:12:30 CST 2023, time=2023-02-28, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2097755, encodeId=05a3209e75549, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=20b14243701, createdName=13e2e3cbm26暂无昵称, createdTime=Tue Nov 01 09:29:42 CST 2022, time=2022-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1224261, encodeId=047e1224261c2, content=学到很多东西！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/b1wvblgVe3DzeVwvHZ1RvcUDjV5rdn37aluS21NEb5eH9WE20J7GzMGmZytribqdI1Yz2uSsibpkNVUz608aukFw/132, createdBy=04e95230639, createdName=lichifeng, createdTime=Fri Jun 03 16:19:29 CST 2022, time=2022-06-03, status=1, ipAttribution=)]
2022-06-03 lichifeng

学到很多东西！

44 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

呼吸指南

2022 GOLD慢性阻塞性肺疾病全球倡议：COPD诊断、治疗与预防全球策略

相关指南

拓展阅读

科室

工具

服务